Certara releases new versions of its preeminent quantitative systems pharmacology (qsp) simulators for expediting development of biologics and immuno-oncology therapies

Expanded capabilities in company's immunogenicity and immuno-oncology qsp simulators broaden applicability for addressing safety and efficacy challenges expanded capabilities in company's immunogenicity and immuno-oncology qsp simulators broaden applicability for addressing safety and efficacy challenges
CERT Ratings Summary
CERT Quant Ranking